8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)	November 17, 2008
Hydromer, Inc. (Exact name of registrant as specified in its chapter)
New Jersey (State or other jurisdiction of incorporation)	0-10683 (Commission File Number)	22-2303576 (IRS Employer Identification No.)

35 Industrial Parkway Branchburg, N.J. (Address of principal executive offices) 08876 (Zip Code)

Registrant's telephone number, including area code (908) 722 – 5000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

(  )  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

(  )  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

(  )  Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

(  )  Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240-13e-4(c))

Item 8.01. Other Events

Press Release Announcing that Hydromer, Inc. enters Chinese Market.

EXHIBIT INDEX

Exhibit No.	Description of Exhibit
99.36	Press Release issued November 17, 2008

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Hydromer, Inc.  Registrant  /s/ Robert Y. Lee
Date November 17, 2008	Robert Y. Lee Chief Financial Officer

EX-99.36

Hydromer, Inc.	35 Industrial Parkway;  Branchburg, NJ  08876;  U.S.A.
	Tel: (908) 722-5000 • Fax: (908) 526-3633 • http://www.hydromer.com
	Video Conferencing IP Address: video.hydromer.com

PRESS RELEASE:	The following is available for immediate release:
	Branchburg, New Jersey; November 17, 2008
	From:	Hydromer, Inc.
		35 Industrial Parkway
		Branchburg, New Jersey 08876-3424
	Contact:	Martin von Dyck, ExecutiveVice President
		(908) 722-5000

Hydromer, Inc. enters Chinese Market

Hydromer, Inc. (HYDI.OB – OTC BB), announces that it has entered into a Sales Representation Agreement with HnG Medical Incorporatedto represent Hydromer medical coatings in the People’s Republic of China.

Under the terms of this relationship, HnG Medical will represent and negotiate medical coating services and royalty/fee based license agreements in China.

“I am delighted with our new relationship which will provide Hydromer with access to one of the fastest growing economies in the world.” commented Martin von Dyck, Executive Vice President of Hydromer, Inc., adding, “What is of significant importance is that HnG Medical will aid Hydromer in the preparation of medical coating agreements to be enforceable under Chinese law and providing protection for Hydromer’s intellectual property.”

In addition to the Urinary catheter and Central Venous Catheter and Cardiovascular Stent businesses, HnG Medical will focus on the application of Hydromer’s proprietary Hydromer® hydrophilic coatings on various Pebax®, Polyamide and Polyurethane cardiovascular, neurovascular and similar microcatheters catheters.

HnG Medical Incorporated is headquartered in Ontario, Canada with offices in the Ningbo Free Trade Zone, China.  The company supplies manufacturing equipments and raw materials to Chinese medical device manufacturers.  Backed by profound knowledge, rich experience in disposable medical devices, HnG is offering consultation services and supplying manufacture equipments to manufacturers. HnG provides most advanced and top quality manufacture equipments and materials.  Please visit our web site at http://www.hngmedical.com ..

Pebax ® is a registered trademark of Arkema.

For additional information please contact: Martin von Dyck, 908-722-5000, Executive Vice President.

Hydromer, Inc. is a technology-based company involved in the research and development, manufacture and commercialization of specialized polymer and hydrogel products for medical device, pharmaceutical, animal health, cosmetic, personal care, and industrial uses.  For the latest information about Hydromer, Inc. and its products, please visit our web site at http://www.hydromer.com.